David Charles Baker
Director · GRI Bio, Inc.
Individual
- 2025
- Sep 18, 2025
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at David Charles Baker's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Charles Baker?
David Charles Baker is a corporate insider, tracked as Director of GRI Bio, Inc. (GRI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David Charles Baker last file a Form 4?
The most recent primary Form 4 on record is dated 18 September 2025, one of 3 filings going back to 2025.